Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
Price Target
Average
2.34%
Revenue Forecast
Estimate
61.37%
EBIT
Estimate
--2.15%
Net Income
Estimate
52.84%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Axsome Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AXSM of $131 , with forecasts ranging from
a
low of
$106 to a high of $190 .
AXSM Lowest Price Target
Wall Street Target
106 USD
-17.19%
AXSM Average Price Target
Wall Street Target
131 USD
2.34%
AXSM Highest Price Target
Wall Street Target
190 USD
48.44%
REVENUE FORECAST
Revenue Forecast Chart AXSM
EBIT FORECAST
EBIT Forecast Chart AXSM
NET INCOME FORECAST
Net Income Chart AXSM